Top

Annals of Hematology

Published in:

01-02-2013 | Letter to the Editor

Renal failure secondary to leukemic infiltration of kidneys in CLL—a case report and review of literature

Authors: Dipesh Uprety, Alan Peterson, Binay Kumar Shah

Published in: Annals of Hematology | Issue 2/2013

Excerpt

Dear Editor, …

Barcos M, Lane W, Gomez GA, Han T, Freeman A, Preisler H, Henderson E (1987) An autopsy study of 1206 acute and chronic leukemias (1958 to 1982). Cancer 60(4):827–837PubMedCrossRef

Schwartz JB, Shamsuddin AM (1981) The effects of leukemic infiltrates in various organs in chronic lymphocytic leukemia. Hum Pathol 12(5):432–434PubMedCrossRef

Da’as N, Polliack A, Cohen Y, Amir G, Darmon D, Kleinman Y, Goldfarb AW, Ben-Yehuda D (2001) Kidney involvement and renal manifestations in non-Hodgkin’s lymphoma and lymphocytic leukemia: a retrospective study in 700 patients. Eur J Haematol 67(3):158–164PubMedCrossRef

Dou X, Hu H, Ju Y, Liu Y, Kang K, Zhou S, Chen W (2011) Concurrent nephrotic syndrome and acute renal failure caused by chronic lymphocytic leukemia (CLL): a case report and literature review. Diagn Pathol 6:99, doi:10.1186/1746-1596-6-99 PubMedCrossRef

Ferreira AC, Brum S, Carvalho D, Pataca I, Carvalho F, Santos MC, Santos JR (2010) Renal dysfunction due to leukemic infiltration of kidneys in a case of chronic lymphocytic leukemia. Hemodial Int 14(1):87–90PubMedCrossRef

Sangala N, Dewdney A, Marley N, Cranfield T, Venkat-Raman G (2011) Progressive renal failure due to renal infiltration by polyomavirus and leukaemic cells: which is the culprit? NDT Plus 4:46–48CrossRef

Inoue T, Sato T, Okada H, Kayano H, Watanabe Y, Kikuta T, Tsuda M, Sueyoshi K, Takenaka T, Suzuki H (2010) Granulomatous interstitial nephritis in chronic lymphocytic leukaemia. Nephrol Dial Transplant 25(12):4107–4109PubMedCrossRef

Hewamana S, Pepper C, Jenkins C, Rowntree C (2009) Acute renal failure as the presenting feature of leukaemic infiltration in chronic lymphocytic leukaemia. Clin Exp Nephrol 13(2):179–181PubMedCrossRef

Rifkin SI (2008) Acute renal failure secondary to chronic lymphocytic leukemia: a case report. Medscape J Med 10(3):67PubMed

10.

Rockx MA, Rizkalla K, Clark WF (2008) Acute renal failure and chronic lymphocytic leukaemia. Nephrol Dial Transplant 23(2):770–771PubMedCrossRef

11.

Kamat AV, Goldsmith D, O’Donnell P, van der Walt J, Carr R (2007) Renal failure with granulomatous interstitial nephritis and diffuse leukemic renal infiltration in chronic lymphocytic leukemia. Ren Fail 29(6):763–765PubMedCrossRef

12.

Erten N, Saka B, Caliskan YK, Besisik S, Karan MA, Tascioglu C (2005) Acute renal failure due to leukaemic infiltration in chronic lymphocytic leukaemia: case report. Int J Clin Pract Suppl 59(147):53–55CrossRef

13.

Boudville N, Latham B, Cordingly F, Warr K (2001) Renal failure in a patient with leukaemic infiltration of the kidney and polyomavirus infection. Nephrol Dial Transplant 16(5):1059–1061PubMedCrossRef

14.

Comerma-Coma MI, Sans-Boix A, Tuset-Andújar E, Andreu-Navarro J, Pérez-Ruiz A, Naval-Marcos I (1998) Reversible renal failure due to specific infiltration of the kidney in chronic lymphocytic leukaemia. Nephrol Dial Transplant 13:1550–1552PubMedCrossRef

15.

Phillips JK, Bass PS, Majumdar G, Davies DR, Jones NF, Pearson TC (1993) Renal failure caused by leukaemic infiltration in chronic lymphocytic leukaemia. J Clin Pathol 46(12):1131–1133PubMedCrossRef

16.

Haraldsdóttir V, Haanen C, Jordans JG (1992) Chronic lymphocytic leukaemia presenting as renal failure with lymphocytic infiltration of the kidneys. Neth J Med 41(1–2):64–67PubMed

17.

Tucker B, Brown AL, d’Ardenne AJ, Cattell WR (1990) Reversible renal failure due to renal infiltration and associated tubulointerstitial disease in chronic lymphocytic leukaemia. Nephrol Dial Transplant 5(8):616–618PubMedCrossRef

18.

Saggi S, Calandri C, Muhlfelder T, Choi H, Kahn T, Kaji D (1990) Renal failure due to leukaemic infiltration in chronic lymphocytic leukaemia. Nephrol Dial Transplant 5:1051–1052PubMedCrossRef

19.

Pagniez DC, Fenaux P, Delvallez L, Dequiedt P, Gosselin B, Tacquet A (1988) Reversible renal failure due to specific infiltration on chronic lymphocytic leukemia. Am J Med 85:579–580PubMedCrossRef

Title: Renal failure secondary to leukemic infiltration of kidneys in CLL—a case report and review of literature
Authors: Dipesh Uprety
Alan Peterson
Binay Kumar Shah
Publication date: 01-02-2013
Publisher: Springer-Verlag
Published in: Annals of Hematology / Issue 2/2013
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-012-1547-6

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2013

Cytogenetic response to imatinib treatment in Southern Brazilian patients with chronic myelogenous leukemia and variant Philadelphia chromosome

Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia

Using a cut-off SUV level to define bone marrow lesions on FDG PET is not appropriate

Effect of different doses of iron supplementation during pregnancy on maternal and infant health

Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload

Repression of STAT3, STAT5A, and STAT5B expressions in chronic myelogenous leukemia cell line K–562 with unmodified or chemically modified siRNAs and induction of apoptosis

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials